there was no significant effect of a daily multivitamin on prostate cancer (hr, 0.98; 95% ci, 0.88–1.09; p=0.76), colorectal cancer (hr, 0.89; 95% ci, 0.68–1.17; p=0.39), or other site-specific cancers there was a lower risk of cancer mortality that did not reach statistical significance (hr, 0.88; 95% ci, 0.77–1.01; p=0.07).